期刊文献+

人生长分化因子15的原核表达、纯化与多克隆抗体制备 被引量:1

Prokaryotic Expression and Purification of Human Growth Differentiation Factor-15 and Preparation of its Polyclonal Antibody
下载PDF
导出
摘要 目的:原核表达并纯化、鉴定人生长分化因子15(GDF-15),制备其多克隆抗体。方法:从人结肠癌细胞系HT29的cDNA扩增出GDF-15基因片段并插入pET-32a(+)原核表达载体,转化大肠杆菌BL21,IPTG诱导表达重组GDF-15,用镍亲和柱纯化,SDS-PAGE、Western印迹鉴定重组蛋白。用纯化的重组GDF-15免疫BALB/c小鼠制备多克隆抗体,鉴定并检测其效价。结果:制备了pET-32a(+)-GDF-15表达载体;经IPTG诱导重组蛋白表达后,采用Ni亲和柱纯化蛋白,并经SDS-PAGE和免疫印迹鉴定;免疫BALB/c小鼠后获得了GDF-15多克隆抗体,ELISA检测抗体效价为1∶100000,并应用于肿瘤细胞的GDF-15检测中。结论:用基因工程和免疫学方法制备了重组人GDF-15及其多克隆抗体,为后续的分子机制和靶向治疗研究奠定了基础。 Objective: To express recombinant differentiation factor-15(GDF-15) in Escherichia coli,and to puri-fy and identify the fusion protein,prepare the polyclonal antibody against GDF-15.Methods: The gene of GDF-15 was cloned according to the cDNA from the colon cancer cell HT29.Then the synthesized GDF-15 gene wasinserted into p ET-32 a prokaryotic expression vector and the plasmid was transformed into E.coli BL21.The fusionprotein was expressed with IPTG induction,purified by Ni-affinity chromatography and identified by SDS-PAGEand Western blot.A polyclonal antibody was developed by immunizing BALB/c mice with the purified fusion pro-tein,the titer was determined and the specificity was identified by Western blot.Results: The recombinant plas-mid was verified to be correct by restriction enzyme digestion andDNA sequencing.The fusion protein expressedwith IPTG induction and purified by Ni-affinity chromatography,was proved to be GDF-15 by Western blot.Andget a polyclonal antibody with a titer of 1∶100 000.Conclusion: We have purified GDF-15 fusion protein andprepared the antibody against GDF-15 successfully,which provided the basis for the research of mechanism andthe target of the therapy.
出处 《生物技术通讯》 CAS 2015年第3期334-337,共4页 Letters in Biotechnology
基金 国家自然科学基金(81171978 81301785)
关键词 人生长分化因子15 融合蛋白 基因工程 表达纯化 多克隆抗体 growth differentiation factor-15 fusion protein genetic engineering expression and purication polyclonal antibody
  • 相关文献

参考文献15

  • 1Constam D B, Robertson E J. Regulation of bone morphogenet- ic protein activity by pro domains and proprotein convertases [J]. J Cell Biol, 1999,144(1):139-149.
  • 2Unsicker K, Spittau B, Krieglstein K. The multiple facets of the TGF-13 family eytokine growth/differentiation factor-15/ macrophage inhibitory cytokine-l[J]. Cytokine Growth Factor Rev, 2013,24(4):373-384.
  • 3Schlittenhardt D, Schober A, Strelau J, et al. Involvement of growth differentiation factor-15/macrophage inhibitory eytokine- I(GDF-15/MIC-I) in oxLDl,-induced apoptosis of human mac- rophages in vitro and in arteriosclerotic lesions[J]. Cell Tissue Res, 2004,318(2):325-333.
  • 4Zhou Z, Li W, Song Y, et al. Growth differentiation factor-15 suppresses maturation and function of dendritic cells and in- hibits tumor-specific immune response[J]. PLoS One, 2013,8 (11):e78618.
  • 5Roth P, Junker M, Tritschler I, et al. GDF-15 Contributes to proliferation and immune escape of malignant gliomas[J]. Clin Cancer Res, 2010,16(15):3851-3859.
  • 6Strelau J, Sehmeer C, Peterziel H, et al. Expression and puta- tive functions of GDF-15, a member of the TGF-beta super- family, in human glioma and glioblastoma cell lines[J]. Can- cer Lett, 2008,270(1):30-39.
  • 7Staff A C, Trovik J, Zahl E A G, et al. Elevated plasma growth differentiation factor-15 correlates with lymph node me- tastases and poor survival in endometrial cancer[J]. Clin Can- cer Res, 9011,17(14):4825-4833.
  • 8Brown D A, Hauce K W, Rogers C J, et al. Serum macro- phage inhibitory cytokine-l(MIC-l/GDFlS): a potential screen- ing tool for the prevention of colon cancer[J]? Cancer Epide- miol Biomarkers Prevention, 2012,21(2):337-346.
  • 9Wakefield L M, Hill C S. Beyond TGF-[3: roles of other TGF-[$ superfamily members in cancer[J]. Nat Rev Cancer, 2013,13(5):328-341.
  • 10Mimeauh M, Batra S K. Divergent molecular mechanisms un- derlying the pleiotropic functions of macrophage inhibitory cy- tokine-I in cancer[J]. J Cell Physio], 2010,224(3):626-635.

二级参考文献22

  • 1赵旭旻,周利群,翁迈,辛殿祺,那彦群,郭应禄.前列腺癌中巨嗜细胞抑制细胞因子-1基因的表达及意义[J].基础医学与临床,2005,25(7):632-636. 被引量:2
  • 2Bauskin AR, Bootcov MR, Valenzuela SM, et al. MIC - 1, a novel macrophage inhibitory cytokine is a divergent member of the TGF - bate superfamily cluster [ J ]. Proc Natl Acad Sci Usa,1997,94(21 ) :11514 - 11519.
  • 3Welsh JB, Sapinoso LM, Kern SG, et al. Large - scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum [ J ]. Proc Natl Acad Sci USA, 2003, 100:3410 - 3415.
  • 4Schober A, Bottner M, Strlau J, et al. Expression of growth differentiation fator - 15/macrophage inhibitory cytokine - 1 (GDF- 15/MIC -1)in perinatal adult, and injured rat brain [ J ]. Comp Neurol, 2001,439:32 - 45.
  • 5Fairlie WD, Moore AG, Bauskin AR, et al. MIC - 1 is anovel TGF-β superfamily Cytokine associated with macrophage activation [J]. Leukocyte Biol, 1999,65:2 - 5.
  • 6Mcore AG, Brown DA, Fairlie WD, et al. The transforming growth factor - β superfamily cytokine macrophage inhibitory cytokinesis present in high concentrations in the serum of pregnant women [ J ]. Clin Endocrinol Metab, 2000, 85 (12) :4781 -4788.
  • 7Brown DA, Stephan C, Ward RL, et al. Serum marcrophage inhibitory eytokine - 1 ( MIC - 1 ) levels forthe diagnosis of prostate cancer[ J]. Clinical Cancer Res ,2006,12:89 - 96.
  • 8Lee DH, Yang Y, Lee SJ, et al. Macrophage inhibitory cytokine - 1 induces the invasiveness of gastric cancer ceils by upregulating the rokinase -type plasminogen activator system[ J ]. Cancer Res ,2003,63:4648 - 4655.
  • 9kcopmann J, RosenZweig CN, Zhang Z, et al. serum markers in patients with respectable pancreatic adenocarcincma MIC - 1VS CA - 199 [ J ]. Clin Cancer Res, 2006,12 (2) : 442 - 446.
  • 10Koopmann J, Buckhaults P, Brown DA, et al. Serum macrophage inhibitory cytokine lasa marker of pancreatic and other periampullary cancers [ J ]. Clin Cancer Res, 2004, 10:2386 - 2392.

共引文献1

同被引文献8

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部